New Anticoagulant Prompts Bad Blood between Partners

Yale University and Corvas are battling over a patent on a hookworm molecule that can be used as an anticoagulant. Yale currently holds the patent, but Corvas has filed for another one, saying their research goes further.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Science (American Association for the Advancement of Science) 1996-03, Vol.271 (5257), p.1800-1801
1. Verfasser:	Friedly, Jock
Format:	Artikel
Sprache:	eng
Schlagworte:	Amino Acid Sequence Anticoagulants Anticoagulants (Medicine) Anticoagulants - chemistry Anticoagulants - isolation & purification Anticoagulants - pharmacology Biotechnology Biotechnology industries Biotechnology industry Blood DNA, Complementary Helminth Proteins - chemistry Helminth Proteins - isolation & purification Helminth Proteins - pharmacology Hookworms Humans Industry Intellectual Property Molecules News and Comment Patents as Topic Proteins Research Directors Researchers Scientists Thromboplastin - genetics Universities Worms
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Yale University and Corvas are battling over a patent on a hookworm molecule that can be used as an anticoagulant. Yale currently holds the patent, but Corvas has filed for another one, saying their research goes further.
ISSN:	0036-8075 1095-9203
DOI:	10.1126/science.271.5257.1800.a